ABA Journal examines how biotechnology law and patents on genes can change the cost of health care in the future. The story reveals that "about patent 1,000 applications involving human or animal DNA have been filed, and about 200 patents have been issued during the past five or so years." The report looks at the possible implications - both positive and negative for the public - of corporate interests involved in biotech research.
This file is not available for digital download. IRE members may place an order by emailing firstname.lastname@example.org